In this analysis of long-term clinical outcomes, over 50% of PNH patients treated with C5is did not have a Hb response (Hb ≥ 1 g/dL increase from baseline) or normalization (Hb ≥ 12 g/dL). Here, GSTM1 is linked to paroxysmal nocturnal hemoglobinuria.